Pages that link to "Q35847850"
Jump to navigation
Jump to search
The following pages link to High-level hepatitis B virus replication in transgenic mice (Q35847850):
Displaying 50 items.
- Carboxypeptidase D is an avian hepatitis B virus receptor (Q24527304) (← links)
- Activation of hepatitis B virus S promoter by a cell type-restricted IRE1-dependent pathway induced by endoplasmic reticulum stress (Q24529972) (← links)
- Hepatitis B virus replication (Q24563894) (← links)
- Viral and cellular determinants involved in hepadnaviral entry (Q24563902) (← links)
- Targeted DNA mutagenesis for the cure of chronic viral infections (Q24620150) (← links)
- HBV pathogenesis in animal models: recent advances on the role of platelets (Q24672103) (← links)
- Advances and Challenges in Studying Hepatitis B Virus In Vitro (Q26771134) (← links)
- Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes (Q26772317) (← links)
- Contributions of transgenic mouse studies on the research of hepatitis B virus and hepatitis C virus-induced hepatocarcinogenesis (Q26775804) (← links)
- Immune-mediated Liver Injury in Hepatitis B Virus Infection (Q26786772) (← links)
- Mouse models of hepatitis B virus infection comprising host-virus immunologic interactions (Q27002598) (← links)
- Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases (Q27024630) (← links)
- Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis (Q27349825) (← links)
- Stealth and cunning: hepatitis B and hepatitis C viruses (Q27470232) (← links)
- Efficacy of cationic lipid–DNA complexes (CLDC) on hepatitis B virus in transgenic mice (Q27486380) (← links)
- Mouse models in liver cancer research: A review of current literature (Q27490350) (← links)
- Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment (Q27490974) (← links)
- The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses (Q28271798) (← links)
- Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus (Q28365198) (← links)
- Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine (Q28368198) (← links)
- Hepatitis B virus molecular biology and pathogenesis (Q28818406) (← links)
- Immunology of hepatitis B virus and hepatitis C virus infection (Q29618957) (← links)
- CD40 activation rescues antiviral CD8⁺ T cells from PD-1-mediated exhaustion. (Q31123164) (← links)
- A self-processing ribozyme cassette: utility against human papillomavirus 11 E6/E7 mRNA and hepatitis B virus (Q33201845) (← links)
- Detailed characterization of the peptide binding specificity of five common Patr class I MHC molecules (Q33247553) (← links)
- Hepatitis B virus X protein impairs hepatic insulin signaling through degradation of IRS1 and induction of SOCS3. (Q33547349) (← links)
- Sustained Inhibition of HBV Replication In Vivo after Systemic Injection of AAVs Encoding Artificial Antiviral Primary MicroRNAs (Q33635361) (← links)
- Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice. (Q33639557) (← links)
- Immune effectors required for hepatitis B virus clearance (Q33640225) (← links)
- Transcriptional repression of human hepatitis B virus genes by a bZIP family member, E4BP4. (Q33644750) (← links)
- Natural killer cell activation contributes to hepatitis B viral control in a mouse model (Q33670723) (← links)
- Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes (Q33677323) (← links)
- Genomic analysis of the host response to hepatitis B virus infection (Q33696514) (← links)
- Comparative study of anti-hepatitis B virus RNA interference by double-stranded adeno-associated virus serotypes 7, 8, and 9. (Q33713259) (← links)
- H-2 Kd-restricted hepatitis B virus-derived epitope whose specific CD8+ T lymphocytes can produce gamma interferon without cytotoxicity (Q33754985) (← links)
- Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs (Q33756729) (← links)
- Inhibition of Hepatitis B Virus Replication during Adenovirus and Cytomegalovirus Infections in Transgenic Mice (Q33782971) (← links)
- Effect of dipterinyl calcium pentahydrate on hepatitis B virus replication in transgenic mice (Q33784869) (← links)
- Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice (Q33787132) (← links)
- Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. (Q33788761) (← links)
- Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. (Q33798736) (← links)
- Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice (Q33803549) (← links)
- Intracellular hepatitis B virus nucleocapsids survive cytotoxic T-lymphocyte-induced apoptosis (Q33812052) (← links)
- La autoantigen specifically recognizes a predicted stem-loop in hepatitis B virus RNA (Q33815588) (← links)
- In vivo regulation of hepatitis B virus replication by peroxisome proliferators (Q33825523) (← links)
- Role of NF-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein (Q33834716) (← links)
- Immune tolerance split between hepatitis B virus precore and core proteins (Q33835018) (← links)
- A short N-proximal region in the large envelope protein harbors a determinant that contributes to the species specificity of human hepatitis B virus (Q33849892) (← links)
- Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier. (Q33851759) (← links)
- Hepatitis B virus biology (Q33855246) (← links)